Neuropathic Pain and Traditional Medicine Syndromes in Herpes Zoster: a Cross-Sectional Study
NCT ID: NCT06870877
Last Updated: 2025-03-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
80 participants
OBSERVATIONAL
2025-02-28
2025-05-12
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Survey on the Characteristics of Traditional Medicine Syndromes in Urticaria Patients At Le Van Thinh Hospital
NCT06859736
The Efficacy and Safety of Herbal Medicine Treatment for Obese Patients With Spinal and Joint Pain
NCT06859697
Clinical Research of Effectiveness and Safety of Herbal Medicine Strategy for Chronic Low Back Pain
NCT07058376
Evaluation of Clinical Efficacy of Herbal Compound in the Treatment of NSLBP
NCT06336993
TCM Etiological Study on the Theory of XuSunShengJi in Liver Cirrhosis
NCT00540397
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The primary objectives of the study are:
To determine the prevalence of different TCM syndromes in HZ patients. To analyze the correlation between LANSS scores and specific TCM syndromes. To provide insights into the integration of objective neuropathic pain assessment tools with traditional diagnostic frameworks.
Data collection includes demographic characteristics, medical history, pain characteristics, TCM diagnostic features, and clinical examination results. Statistical analyses include correlation tests and multinomial logistic regression to assess the relationship between LANSS pain scores and TCM syndromes.
The study findings will contribute to a better understanding of the relationship between neuropathic pain and TCM syndromes in Herpes Zoster. The results may help refine diagnostic approaches and optimize integrative treatment strategies for pain management in patients with HZ.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Clinically diagnosed with Herpes Zoster (HZ) based on European Consensus Guidelines
* Experiencing neuropathic pain associated with HZ
* Willing to provide informed consent
Exclusion Criteria
* Receiving immunosuppressive therapy or diagnosed with immunodeficiency disorders
* Patients who had already received antiviral or analgesic treatment before evaluation
* Patients unable or unwilling to provide informed consent
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Do Thanh Sang
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Do Thanh Sang
University of Medicine and Pharmacy at Ho Chi Minh City
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Le Van Thinh Hospital
Ho Chi Minh City, Viet Nam, Vietnam
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Sang Do
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
78/HĐĐĐ-ĐHYD
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.